NDC 68135-020-01
NAGLAZYME 5 mg/5mL
galsulfase · SOLUTION
Naglazyme (galsulfase) is an intravenous enzyme replacement therapy used to treat mucopolysaccharidosis VI (MPS VI), a rare genetic disorder in which the body cannot break down certain complex sugars. This medication helps reduce the buildup of these substances in the body to improve symptoms and slow disease progression.
Key Facts
- Brand Name
- NAGLAZYME
- Generic Name
- galsulfase
- NDC Code (Package)
68135-020-01- NDC Code (Product)
68135-020- Manufacturer
- BioMarin Pharmaceutical Inc.
- Strength
- 5 mg/5mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125117
- Drug Class
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
- Marketing Start
- 06/09/2005
Recall History
No Recall HistoryView Full Drug Page
NAGLAZYME — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.